Using a mix of in vitro and in vivo models, including subcutaneous xenograft and lung metastasis models, they found that treatment with their TF-directed CAR T therapy suppressed the growth and metastasis of cancer cells that were TF positive. This evidence concerns the gene TF and cancer.